Kang S - Search Results

1

Evaluation of the efficacy and safety of anti-PD-1 and anti-PD-L1 antibody in the treatment of non-small cell lung cancer (NSCLC): a meta-analysis.

Jia M, Feng W, Kang S, Zhang Y, Shen J, He J, Jiang L, Wang W, Guo Z, Peng G, Chen G, He J, Liang W. Jia M, et al. Among authors: kang s. J Thorac Dis. 2015 Mar;7(3):455-61. doi: 10.3978/j.issn.2072-1439.2015.02.06. J Thorac Dis. 2015. PMID: 25922725 Free PMC article.

2

Network meta-analysis on prophylactic regimens against recurrent hepatitis B virus infection after liver transplantation.

Zhang Y, Kang S, Fang W, Wu X, Liang W. Zhang Y, et al. Among authors: kang s. Hepatobiliary Surg Nutr. 2013 Dec;2(6):297-303. doi: 10.3978/j.issn.2304-3881.2013.11.02. Hepatobiliary Surg Nutr. 2013. PMID: 24570966 Free PMC article.

3

Patients with exon 19 deletion were associated with longer progression-free survival compared to those with L858R mutation after first-line EGFR-TKIs for advanced non-small cell lung cancer: a meta-analysis.

Zhang Y, Sheng J, Kang S, Fang W, Yan Y, Hu Z, Hong S, Wu X, Qin T, Liang W, Zhang L. Zhang Y, et al. Among authors: kang s. PLoS One. 2014 Sep 15;9(9):e107161. doi: 10.1371/journal.pone.0107161. eCollection 2014. PLoS One. 2014. PMID: 25222496 Free PMC article.

4

ABO blood group, Epstein-Barr virus infection and prognosis of patients with non-metastatic nasopharyngeal carcinoma.

Zhang YX, Kang SY, Chen G, Fang WF, Wu X, You HJ, He DC, Cao YL, Liang WH, Zhang L. Zhang YX, et al. Asian Pac J Cancer Prev. 2014;15(17):7459-65. doi: 10.7314/apjcp.2014.15.17.7459. Asian Pac J Cancer Prev. 2014. PMID: 25227859 Free article.

5

Impact of EGFR mutation status on tumor response and progression free survival after first-line chemotherapy in patients with advanced non-small-cell lung cancer: a meta-analysis.

Liang W, Zhang Y, Kang S, Pan H, Shao W, Deng Q, Shi X, Wang W, He J. Liang W, et al. Among authors: kang s. J Thorac Dis. 2014 Sep;6(9):1239-50. doi: 10.3978/j.issn.2072-1439.2014.07.33. J Thorac Dis. 2014. PMID: 25276366 Free PMC article.

6

Multi-targeted antiangiogenic tyrosine kinase inhibitors in advanced non-small cell lung cancer: meta-analyses of 20 randomized controlled trials and subgroup analyses.

Liang W, Wu X, Hong S, Zhang Y, Kang S, Fang W, Qin T, Huang Y, Zhao H, Zhang L. Liang W, et al. Among authors: kang s. PLoS One. 2014 Oct 16;9(10):e109757. doi: 10.1371/journal.pone.0109757. eCollection 2014. PLoS One. 2014. PMID: 25329056 Free PMC article.

7

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy.

Fang W, Zhang J, Hong S, Zhan J, Chen N, Qin T, Tang Y, Zhang Y, Kang S, Zhou T, Wu X, Liang W, Hu Z, Ma Y, Zhao Y, Tian Y, Yang Y, Xue C, Yan Y, Hou X, Huang P, Huang Y, Zhao H, Zhang L. Fang W, et al. Among authors: kang s. Oncotarget. 2014 Dec 15;5(23):12189-202. doi: 10.18632/oncotarget.2608. Oncotarget. 2014. PMID: 25361008 Free PMC article.

8

Impact of smoking status on EGFR-TKI efficacy for advanced non-small-cell lung cancer in EGFR mutants: a meta-analysis.

Zhang Y, Kang S, Fang W, Hong S, Liang W, Yan Y, Qin T, Tang Y, Sheng J, Zhang L. Zhang Y, et al. Among authors: kang s. Clin Lung Cancer. 2015 Mar;16(2):144-151.e1. doi: 10.1016/j.cllc.2014.09.008. Epub 2014 Oct 2. Clin Lung Cancer. 2015. PMID: 25454007 Free article.

9

Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.

Chen N, Fang W, Zhan J, Hong S, Tang Y, Kang S, Zhang Y, He X, Zhou T, Qin T, Huang Y, Yi X, Zhang L. Chen N, et al. Among authors: kang s. J Thorac Oncol. 2015 Jun;10(6):910-23. doi: 10.1097/JTO.0000000000000500. J Thorac Oncol. 2015. PMID: 25658629 Free article.

10

The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis.

Zhang Y, Fang W, Yan Y, Wang M, Kang S, Sheng J, Zhan J, Chen N, Hong S, Yang Y, Ma Y, He D, Qin T, Zhou T, Tang Y, He X, Liang W, Zhang L. Zhang Y, et al. Among authors: kang s. Med Oncol. 2015 Mar;32(3):61. doi: 10.1007/s12032-015-0489-y. Epub 2015 Feb 8. Med Oncol. 2015. PMID: 25663066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,628 results

Search Page

Filters